Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

GSK options several boron drug candidates from Anacor

Executive Summary

Anacor Pharmaceuticals (topical compounds for fungal, bacterial, and inflammatory diseases) has given GlaxoSmithKline options to exclusively license worldwide rights to several of its boron-containing antiviral and antibacterial candidates in a six-year deal that may be extended up to two years.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Contract
    • R+D and Marketing-Licensing
    • Includes Royalty or Profit Split Information
    • Includes Equity

Related Companies

UsernamePublicRestriction

Register